Recently, Dr. Sun Yimin, President of CapitalBiotech, along with Dr. Li Yanze, Assistant President, visited Kyrgyzstan to hold a working meeting with officials from the Chinese Embassy in Kyrgyzstan. During the same period, at the 19th MedExpo Kyrgyzstan, Kanatbek Temirbekovich Bekboyev, Minister of Health of Kyrgyzstan, visited the CapitalBiotech’ booth and held in-depth discussions with Dr. Sun and his delegation, further advancing the construction of the Kyrgyzstan National Precision Medicine Center.
As the joint construction of the Belt and Road Initiative enters a new stage of high-quality development, CapitalBiotech is committed to seizing this opportunity and working closely with Kyrgyz partners to steadfastly promote high-quality cooperation under the BRI framework.
The Impact of DNA Genome Sequencing on Cancer Research and TreatmentJuly 18, 2024Cancer remains one of the most formidable challenges in medical science. As we continually seek innovative solutions to understand and combat this complex disease, DNA genome sequencing has proven to ...view
The Basics and Applications of Genome SequencingNovember 13, 2024Overview of Genome SequencingGenome sequencing refers to the use of high-throughput sequencing platforms to sequence the genomes of different individuals or groups and perform bioinformatics analysis ...view
Application of Genome Sequencing Technology in Newborn ScreeningNovember 13, 2024Newborn screening is a successful public health initiative that prevents diseases and reduces mortality through early diagnosis and disease management. In the era of precision medicine, the expansion ...view